Morning Buzz: KaloBios (KBIO), Can-Fite BioPharma (CANF), Amazon.com (AMZN), Apple (AAPL)

KaloBios Pharmaceuticals, Inc. (KBIO) is up as much as 77% to $46.97 in pre-market trade on Friday after its CEO tweeted: “I spoke with my counsel & advisers and decided to stop lending my KBIO shares out until I better understand the advantages of doing so.” KaloBios has now seen its value surge by 2,500% […] View the full post at: Morning Buzz: KaloBios (KBIO), Can-Fite BioPharma (CANF), Amazon.com (AMZN), Apple (AAPL) Related posts: Amazon’s (AMZN) Cloud: A SaaS Solution Apple’s (AAPL) Short Interest Nosedives Amazon Takes On eBay’s PayPal With New Pay Service